FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions relates to the pharmaceutical or nutraceutical industry, specifically to a xanthophyll composition. Pharmaceutical composition of xanthophylls containing: a) trans-R,R-lutein and trans-R,R-zeaxanthin in amount of 35 wt.% of the total weight of the composition; b) a carrier and/or carrier medium in amount of 51 wt.%, where said carrier and/or carrier medium is medium-chain triglyceride oil; c) a solubility enhancer in amount of 8 wt.%, where said solubility enhancer is mixture of 5 wt.% of olive oil, 1 wt.% of thyme oil and 2 wt.% of linseed oil; d) a flavouring agent in amount of 2 wt.%, where said flavouring agent is D-limonene; e) a bioavailability enhancing agent in amount of 2 wt.%, wherein said bioavailability enhancing agent is phosphatidylcholine; and f) an antioxidant in amount of 2 wt.%, where said antioxidant is mixed tocopherol; in which trans-R,R-lutein and trans-R,R-zeaxanthin are extracted from oil extracts of marigold and paprika, respectively, and are present in ratio of 5:1. Xanthophyll nutraceutical composition containing: a) trans-R,R-lutein and trans-R,R-zeaxanthin in amount of 35 wt.% of the total weight of the composition; b) a carrier and/or carrier medium in amount of 51 wt.%, where said carrier and/or carrier medium is medium-chain triglyceride oil; c) a solubility enhancer in amount of 8 wt.%, where said solubility enhancer is mixture of 5 wt.% of olive oil, 1 wt.% of thyme oil and 2 wt.% of linseed oil; d) a flavouring agent in amount of 2 wt.%, where said flavouring agent is D-limonene; e) a bioavailability enhancing agent in amount of 2 wt.%, wherein said bioavailability enhancing agent is phosphatidylcholine; and f) an antioxidant in amount of 2 wt.%, where said antioxidant is mixed tocopherol; in which trans-R,R-lutein and trans-R,R-zeaxanthin are extracted from oil extracts of marigold and paprika and are present in ratio of 5:1.
EFFECT: above-described xanthophyll compositions have high bioavailability.
20 cl, 8 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION OF VEGETABLE OILS ENRICHED WITH LUTEIN AND ZEAXANTHIN DIESTERS | 2010 |
|
RU2424722C1 |
METHOD OF EXTRACTING XANTHOPHYLLS FROM PLANT MATERIAL | 2010 |
|
RU2436771C1 |
METHOD FOR PREPARING LUTEIN-CONTAINING COMPOSITION, COMPOSITIONS AND THEIR USING | 2002 |
|
RU2303028C2 |
PRIMARY COMPOSITION TO PROVIDE BODY WITH FUNCTIONAL INGREDIENTS, ITS PRODUCTION METHOD AND APPLICATION (VERSIONS), COMPOSITION FOR PERORAL USE (VERSIONS) | 2005 |
|
RU2387136C2 |
BIOLOGICALLY ACTIVE ADDITIVE FOR HENS AND METHOD OF ITS RECEPTION | 2007 |
|
RU2328137C1 |
COMPOSITION CONTAINING NORBIXIN FOR PROTECTING CELLS OF RETINAL PIGMENT EPITHELIUM | 2016 |
|
RU2715889C2 |
XANTHOPHYLL COMPOSITIONS AND METHODS FOR USE THEREOF | 2013 |
|
RU2649618C2 |
SPECIALIZED LIPID MODULE | 2014 |
|
RU2603583C2 |
SYNERGETIC COMBINATIONS FOR TREATING HYPERTENSION | 2008 |
|
RU2459617C2 |
PURE 3R-3′R-STEREOISOMER OF ZEAXANTHIN FOR TREATING YELLOW SPOT DEGENERATION IN PEOPLE | 1996 |
|
RU2197958C2 |
Authors
Dates
2025-06-03—Published
2020-10-10—Filed